For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Aclaris Therapeutics Inc (NASDAQ: ACRS) was $2.06 for the day, down -0.48% from the previous closing price of $2.07. In other words, the price has decreased by -$0.48 from its previous closing price. On the day, 0.51 million shares were traded.
Ratios:
Our analysis of ACRS’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 7.03 and its Current Ratio is at 7.03. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Leerink Partners Upgraded its Market Perform to Outperform on November 19, 2024, whereas the target price for the stock was revised from $2 to $7.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 19 ’24 when Mehra Anand bought 666,666 shares for $2.25 per share. The transaction valued at 1,499,998 led to the insider holds 710,030 shares of the business.
Leonard Braden Michael bought 206,025 shares of ACRS for $256,357 on Aug 05 ’24. The 10% Owner now owns 14,250,000 shares after completing the transaction at $1.24 per share. On Aug 02 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 167,544 shares for $1.29 each. As a result, the insider paid 216,400 and bolstered with 14,043,975 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 8.14 while its Price-to-Book (P/B) ratio in mrq is 1.13.
Stock Price History:
Over the past 52 weeks, ACRS has reached a high of $5.17, while it has fallen to a 52-week low of $0.95. The 50-Day Moving Average of the stock is -19.65%, while the 200-Day Moving Average is calculated to be 12.75%.
Shares Statistics:
A total of 107.02M shares are outstanding, with a floating share count of 90.65M. Insiders hold about 15.30% of the company’s shares, while institutions hold 69.17% stake in the company.
